Explorer les evidences

299 controlsThe study evaluated 299 controls without acquired drug resistance among persons living with HIV receiving combination antiretroviral therapy.

NigeriaVIH/sidaobservé 2004–2011publié 2020AIDS research and therapyPubMeddocument de 7 observations

25 %Two (25%) of the eight participants with presumed ocular toxoplasmosis (POT) were HIV-seropositive.

Nigeriapresumed ocular toxoplasmosis · VIH/sidapublié 2021Ethiopian journal of health sciencesPubMeddocument de 9 observations

22,5 %Among 726 TB patients' records reviewed at the DOTs centre in Federal Medical Centre Abeokuta between January 2015 and December 2019, 186 (22.5%) were co-infected with HIV.

Nigeriatuberculose · VIH/sidaobservé January 2015 to December 2019publié 2022The journal of the Royal College of Physicians of EdinburghPubMeddocument de 6 observations

15 casesThe prevalence of HIV seropositivity among pregnant women in the study was 15 out of 900 participants.

NigeriaVIH/sidapublié 2021Viral immunologyPubMeddocument de 8 observations

4,8 %HIV prevalence among 8306 consenting adults aged ≥15 years in Akwa Ibom state, Nigeria, was 4.8%.

NigeriaVIH/sidaobservé 2017publié 2021Journal of the International AIDS SocietyPubMeddocument de 9 observations

0 %The missed opportunity for antiretroviral therapy initiation among antenatal care attendees was 0% in Adamawa State in Nigeria in 2019.

NigeriaVIH/sidaobservé 2019publié 2023AIDS carePubMeddocument de 7 observations

0,24 AORPeople living with HIV had adjusted odds ratio (AOR) of 0.24 for being hungry but not eating, with 95% confidence interval 0.20–0.30.

NigeriaVIH/sidapublié 2022AIDS and behaviorPubMeddocument de 4 observations

53 %A majority of HIV-infected patients (53.0%) had a CD4 count of less than 500 cells/ml.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 4 observations

48,4 %Of 3495 key populations living with HIV in KP-CBART, 48.4% (n = 1691) had a viral load test.

NigeriaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations

64,1 %Among 168 people living with HIV (PLHIV) studied, 64.1% had fertility desire.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 5 observations

2,01 AORRespondents living with HIV had higher odds for physical violence (AOR: 2.01; 95% CI: 1.46–2.76; p < 0.001).

NigeriaVIH/sidaobservé 2021publié 2022BMC public healthPubMeddocument de 12 observations

13,5 %Depression was cited as a reason for antiretroviral therapy non-adherence in 57 cases (13.5%) among female sex workers who died from HIV/AIDS.

NigeriaVIH/sidaobservé 2022-02-01 to 2023-02-28publié 2026International journal of environmental research and public healthPubMeddocument de 10 observations

3,88 AORLiving with HIV was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 3.88).

NigeriaCOVID-19 · VIH/sidaobservé 2020publié 2022Frontiers in public healthPubMeddocument de 10 observations

28 %Among 224 HIV-1 infected samples from 6 Nigerian cities, the subtype distribution was 28% G.

NigeriaVIH/sidapublié 2016MedicinePubMeddocument de 7 observations

36,91 yearsThe mean age of HIV-infected participants in Port Harcourt was 36.91 years.

NigeriaVIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations

1 342,8 visits_per_monthMean monthly clinic attendance declined from 1,342.8 ± 220.10 visits pre-MMD6 to 1,191.33 ± 309.10 visits post-MMD6.

NigeriaVIH/sidapublié 2023African journal of AIDS research : AJARPubMeddocument de 5 observations

92,7 %92.7% of female artisans in Ibadan, Nigeria had a high level of knowledge about HIV.

NigeriaVIH/sidapublié 2025Women's health (London, England)PubMeddocument de 7 observations

91 %Approximately 91% (421 of 461) of those who received viral load results at month 12 post-enrollment were virally suppressed.

NigeriaVIH/sidaobservé month 12publié 2024BMC public healthPubMeddocument de 6 observations

116 138 individuals116,138 individuals were tested for HIV before the transition period (January–June 2022).

NigeriaVIH/sidaobservé January–June 2022publié 2025BMC health services researchPubMeddocument de 9 observations

2,1 %The North-Western zone of Nigeria recorded an HIV prevalence rate of 2.1%.

NigeriaVIH/sidapublié 2021Nigerian journal of clinical practicePubMeddocument de 7 observations

8 facilitiesBetween baseline (2018) and study-end (May 2022), viral load suppression coverage increased in 8 of the 10 study facilities.

NigeriaVIH/sidaobservé 2018 to May 2022publié 2023BMJ global healthPubMeddocument de 4 observations

27,4 %Unnecessary drug therapy accounted for 27.4% (n=59) of the 215 drug therapy problems identified among PLWH in the study.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 11 observations

20 percentage_pointsThe coverage of antenatal HIV testing in Nigeria grew by 20 percentage points, from 50.1% to 70.5%, between 2013 and 2017.

NigeriaVIH/sidaobservé 2013 to 2017publié 2021Journal of public health (Oxford, England)PubMeddocument de 3 observations

85 %Sub-Saharan Africa is home to 85% of children and adolescents living with HIV globally.

NigeriaVIH/sidapublié 2025International journal of adolescent medicine and healthPubMeddocument de 6 observations

336 persons336 (74.5%) participants had normal visual acuity.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 9 observations